Subscribe to
this category
r

Deals

A total of 82 posts are filed under Deals
Alexion to Expand Pipeline with Syntimmune Acquisition Worth up to $1.2B
Rare Daily Staff Alexion Pharmaceuticals said it has entered into a definitive agreement to acquire Syntimmune, a developer of therapeutics… Continue Reading
Amicus Therapeutics to Acquire Celenex, Scoring Gene Therapy Portfolio for Neurologic Disorders
Rare Daily Staff Amicus Therapeutics agreed to acquire Celenex in a deal that provides it worldwide development and commercial rights for… Continue Reading
Centogene and Evotec Enter Rare Disease Drug Discovery Strategic Partnership
Rare Disease Staff Rare disease diagnostic company Centogene said it has entered into and global strategic collaboration with the drug… Continue Reading
Perlara Enters Collaboration with the University of Notre Dame Focused on Cori Disease and Pompe Disease
Rare Daily Staff Perlara said it has entered into a collaboration with the University of Notre Dame and the Warren Family Research Center… Continue Reading
Mustang Bio Enters License Agreement with St. Jude for X-SCID Gene Therapy
Rare Daily Staff Mustang Bio said it entered into an exclusive worldwide license agreement with St. Jude Children’s Research Hospital for… Continue Reading
OvaScience and Millendo Agree to Merge to Focus on Rare Endocrine Disease
Rare Daily Staff Millendo Therapeutics and OvaScience said they will merge in a $60 million stock swap that will create a public, late-stage… Continue Reading
Acadia Enters License Agreement with Neuren Worth up to $465 Million for Experimental Rett Syndrome Drug
Rare Daily Staff Acadia Pharmaceuticals entered into an exclusive North American license agreement with Neuren Pharmaceuticals for the… Continue Reading
be-a-guest-blogger

Follow us on Twitter